Antimicrobial Susceptibility Patterns and Clinical Characteristics of Corynebacterium striatum Cases from 2018 to 2021
Keywords:
Antimicrobial susceptibility pattern, Corynebacterium striatum, Multidrug resistanceAbstract
Background: Corynebacterium striatum is part of the normal flora of the skin, oral cavity, and intestine. However, it can be a pathogen causing endocarditis, pneumonia, arthritis, and meningitis occasionally. We evaluated the clinical features and antimicrobial susceptibility pattern of C. striatum cases. Methods: Patients infected with C. striatum, who consulted infectious disease physicians and were admitted to Hanyang University Hospital between January 2018 and January 2021, were enrolled for an antimicrobial susceptibility test (AST). We reviewed the medical records of selected patients for information on diagnosis, specimen types, and antibiotics used before and after AST. AST was performed using E-test and interpreted according to the Clinical and Laboratory Standards Institute M45 guidelines. Results: A total of 23 cases were evaluated, and the average age of patients was 58.5 years. Ten cases were diagnosed with sepsis. Eight cases were complicated with cancer, and five cases had wound infections. Four cases were treated with vancomycin prior to AST; in 13 cases, antibiotics were switched to vancomycin after AST. Resistance rates were highest for ciprofloxacin (93.3%), which was followed by cefotaxime (92.3%), penicillin G (87.0%), erythromycin (87.0%), trimethoprim/sulfamethoxazole (78.3%), and meropenem (76.5%). Conclusion: The patients infected by C. striatum were old and immunosuppressed, while many had cancer. Since C. striatum shows resistance to most drugs except vancomycin, we should consider conducting AST before antibiotic treatment.
References
Bernard K, 2012, The Genus Corynebacterium and Other Medically Relevant Coryneform-Like Bacteria. J Clin Microbiol, 50: 3152–3158.
Patricia MT. Bailey and Scott’s Diagnostic Microbiology. 14th edn. 2017, Elsevier, St. Louis, Missouri, 137–158.
Scholle D, 2007, A Spontaneous Joint Infection with Corynebacterium striatum. J Clin Microbiol, 45: 656–658.
Carroll KC, Pfaller MA, Landry ML, et al. Manual of Clinical Microbiology. 12th edn. 2019, American Society for Microbiology Press, Washington, DC, 488–524.
Hong HL, Koh HI, Lee AJ, 2016, Native Valve Endocarditis Due to Corynebacterium striatum Confirmed by 16S Ribosomal RNA Sequencing: A Case Report and Literature Review. Infect Chemother, 48: 239–245.
Renom F, Gomila F, Garau M, et al., 2014, Respiratory Infection by Corynebacterium striatum: Epidemiological and Clinical Determinants. New Microbes New Infect, 2: 106–114
Cone LA, Curry N, Wuestoff MA, et al., 1998, Septic Synovitis and Arthritis Due to Corynebacterium striatum Following an Accidental Scalpel Injury. Clin Infect Dis, 27: 1532–1533.
Weiss K, Labbé AC, Laverdière M, 1996, Corynebacterium striatum Meningitis: Case Report and Review of an Increasingly Important Corynebacterium Species. Clin Infect Dis, 23: 1246–1248.
Song SA, Shin JH, 2018, Microbiological Characteristics of Corynebacterium striatum, an Emerging Pathogen. Hanyang Med Rev, 38: 93–98.
Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria, CLSI M45–ED3. Clinical and Laboratory Standards Institute (CLSI), 2015, Wayne.
Hahn WO, Werth BJ, Butler-Wu SM, et al., 2016, Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs. Emerg Infect Dis, 22: 1908–1914.
Otsuka Y, Ohkusu K, Kawamura Y, et al., 2006, Emergence of Multidrug-Resistant Corynebacterium striatum as a Nosocomial Pathogen in Long-Term Hospitalized Patients with Underlying Diseases. Diagn Microbiol Infect Dis, 54: 109–114.
